Finanzen von Outset Medical Inc (OM)OMOutset Medical Inc

Outset Medical, Inc. (OM) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Consumables, accounting for 39.3% of total sales, equivalent to $12.42M. Other significant revenue streams include Services and other revenue and Consoles. Understanding this composition is critical for investors evaluating how OM navigates market cycles within the Advanced Medical Equipment & Technology industry.

Evaluating the bottom line, Outset Medical, Inc. maintains a gross margin of 40.69%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -36.52%, while the net margin is -43.71%. These profitability ratios, combined with a Return on Equity (ROE) of -63.04%, provide a clear picture of how effectively OM converts its operational activities into shareholder value.

In the context of the broader market, OM competes directly with industry leaders such as WRAP and HYPR. With a market capitalization of $77.08M, it holds a leading position in the sector. When comparing efficiency, OM's gross margin of 40.69% stands against WRAP's 75.29% and HYPR's 50.72%. Such benchmarking helps identify whether Outset Medical, Inc. is trading at a premium or discount relative to its financial performance.

Outset Medical has shown fluctuating revenues, with the latest quarter (2026/Q2) reporting $31.6 million in revenue but a net loss of $17.98 million. The gross margin has improved to 41.99%, which is a positive sign for future profitability.